LeadStory

CBC News

Is this new painkiller a game-changer?

CBC News · 7 days ago
CBC News
CBC News
7 days ago

Suzetrigine is the first new non-opioid painkiller in over 20 years. Unlike opioids, which act in the brain, this drug blocks pain close to where it is happening, meaning it has little possibility of becoming addictive — but experts have other concerns.

BreakdownGenerated by LeadStory AI
  • Suzetrogen is the first new non-opioid painkiller approved in the US in over 20 years.
  • The drug blocks pain in the peripheral nervous system, reducing addiction risk. 20s
  • Trials show suzetrogen is as effective as opioids for acute pain and may have fewer side effects. 30s
  • Suzetrogen is not yet available in Canada, and Health Canada has no submissions under review. 1m 3s
  • Experts raise concerns about high cost, limited evidence for chronic pain, and unknown side effects. 1m 20s
HealthMedical Research